Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/19/2011EP2377527A1 Polyelectrolyte precipitation and purification of antibodies
10/19/2011EP2377526A1 Fast dissolving drug delivery systems
10/19/2011EP2377525A1 Duloxetine enteric pellets
10/19/2011EP2377524A1 Method of stabilizing reduced coenzyme Q10
10/19/2011EP2377523A1 Forms of medicine with improved pharmokinetic characteristics
10/19/2011EP2377522A1 Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
10/19/2011EP2377521A1 Pharmaceutical formulations of telmisartan and diuretic combination
10/19/2011EP2377520A1 Pharmaceutical compound of prasugrel
10/19/2011EP2377517A2 Pharmaceutical composition containing an anionic drug, and a production method therefor
10/19/2011EP2377516A1 Acetaminophen composition
10/19/2011EP2377514A2 Liquid parenteral formulation comprising a tramadol material and paracetamol
10/19/2011EP2377400A1 Antibacterial composition and antiviral composition each containing silicon-containing compound, antibacterializing method, cleaning/mouth cleaning method, and method for immobilizing antibacterial agent or antiviral agent
10/19/2011EP2377398A1 16-ketoaspergillimide and pest exterminating agent comprising the same as active ingredient
10/19/2011EP2376633A1 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
10/19/2011EP2376618A1 Compositions and methods for controlling disease in animals
10/19/2011EP2376532A2 Organic compounds
10/19/2011EP2376519A1 Tgr5 modulators and method of use thereof
10/19/2011EP2376518A1 A complex and method for enhancing nuclear delivery
10/19/2011EP2376516A1 Bis-modified bicyclic nucleic acid analogs
10/19/2011EP2376515A1 Synthesis of purine nucleosides
10/19/2011EP2376513A1 Dimeric avermectin and milbemycin derivatives
10/19/2011EP2376512A2 Derivatives of morphine-6-glucuronid, process for their preparation and their use in therapy
10/19/2011EP2376511A2 Bicyclic derivatives of morphine-6-glucuronid, process for their preparation and their application in therapy
10/19/2011EP2376510A1 Novel aryl c-xyloside compounds, and cosmetic use
10/19/2011EP2376502A1 Thiazolopyridine sirtuin modulating compounds
10/19/2011EP2376501A1 SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS
10/19/2011EP2376500A1 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
10/19/2011EP2376499A1 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
10/19/2011EP2376498A1 Novel c-1analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation
10/19/2011EP2376497A1 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
10/19/2011EP2376496A2 Synthesis of morphine-6-glucuronide or of a derivative thereof
10/19/2011EP2376494A1 Dihydropyrimidopyrimidine derivatives
10/19/2011EP2376493A1 Dihydropyrimidopyrimidine derivative
10/19/2011EP2376492A1 3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
10/19/2011EP2376491A1 Pyrrolotriazines as alk and jak2 inhibitors
10/19/2011EP2376490A1 Imidazopyridine compounds
10/19/2011EP2376489A1 Alkaloid aminoester derivatives and medicinal composition thereof
10/19/2011EP2376488A1 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
10/19/2011EP2376486A1 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/19/2011EP2376485A1 Pyrazine derivatives useful as inhibitors of atr kinase
10/19/2011EP2376484A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
10/19/2011EP2376483A1 Polymorph ii of an antifungal compound
10/19/2011EP2376482A1 Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
10/19/2011EP2376481A1 Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
10/19/2011EP2376480A2 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10/19/2011EP2376479A1 Substituted furancarboxamides, and use thereof
10/19/2011EP2376478A2 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
10/19/2011EP2376475A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
10/19/2011EP2376473A1 3,4 - substituted piperidine derivatives as renin inhibitors
10/19/2011EP2376463A1 Benzothiazole amides for detection of amyloid beta
10/19/2011EP2376462A1 Thiazoles as cannabinoid receptor ligands
10/19/2011EP2376461A1 Nitric oxide furoxan derivative compounds endowed with antitumoral activity
10/19/2011EP2376460A1 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1
10/19/2011EP2376457A2 Crystalline salt forms of flibanserine
10/19/2011EP2376455A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
10/19/2011EP2376454A2 Inhibitors of diacylglycerol acyltransferase
10/19/2011EP2376449A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
10/19/2011EP2376435A2 Synergistic fungicidal compositions including hydrazone derivatives and copper
10/19/2011EP2376433A1 Crystalline form c of tigecycline dihydrochloride and methods for its preparation
10/19/2011EP2376432A1 Novel eicosanoid derivatives
10/19/2011EP2376431A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents
10/19/2011EP2376430A2 New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer
10/19/2011EP2376429A2 Compounds having activity in correcting mutant cftr cellular processing
10/19/2011EP2376428A2 New inhibitors for treating diseases associated with an excess transport of hyaluronan
10/19/2011EP2376425A2 Kinase inhibitor compounds
10/19/2011EP2376424A1 Highly pure cinacalcet or a pharmaceutically acceptable salt thereof
10/19/2011EP2376197A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/19/2011EP2376196A1 Animal treatment formulation and methods of use
10/19/2011EP2376136A2 Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices
10/19/2011EP2376135A1 Use of carboxymethylcellulose to control ejectability and solidification of time of compositions one or more bioresorbable ceramics
10/19/2011EP2376129A1 Chlorhexidine acetate antiseptic cleaning agent
10/19/2011EP2376113A1 Compositions and dosage regimes comprising a clostridial vaccine and levamisole
10/19/2011EP2376092A2 Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens
10/19/2011EP2376091A2 Novel targets for treatment of hypercholesterolemia
10/19/2011EP2376090A1 Inhibition of apoe cleavage activity in the treatment of apoe-related disorders
10/19/2011EP2376089A1 Cancer vaccine compositions and methods of using the same
10/19/2011EP2376088A2 Nucleoside phosphoramidates
10/19/2011EP2376087A1 Erbb-3 (her3)-selective combination therapy
10/19/2011EP2376086A1 Treatment of vaginal atrophy in women with cardiovascular pathology risk
10/19/2011EP2376085A1 Compounds and methods of use
10/19/2011EP2376084A1 Cdk inhibitor for the treatment of mesothelioma
10/19/2011EP2376083A1 Quinazoline inhibitors of bace 1 and methods of using
10/19/2011EP2376082A1 Combination of aurora kinase inhibitors and anti-cd20 antibodies
10/19/2011EP2376081A2 Enzastaurin for the treatment of cancer
10/19/2011EP2376080A1 Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
10/19/2011EP2376079A1 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
10/19/2011EP2376078A2 Deuterated compounds as hepatitis c virus (hcv) inhibitors
10/19/2011EP2376077A2 Composition and method for treatment of diabetes
10/19/2011EP2376076A1 Antitumor combination combining ave8062 and docetaxel
10/19/2011EP2376075A2 Nasal formulations of metoclopramide
10/19/2011EP2376074A1 Method for improved bioactivation of medications
10/19/2011EP2376073A2 Dermal application of vasoconstrictors
10/19/2011EP2376072A1 Arginase inhibitors for the treatment of depression
10/19/2011EP2376068A2 Methods for enhancing the release and absorption of water insoluble active agents
10/19/2011EP2376066A1 Low dose controlled release tablet
10/19/2011EP2376065A2 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
10/19/2011EP2376061A1 Aqueous coacervate composition comprising poorly water-soluble biologically-active agents
10/19/2011EP2376056A1 Cosmetic and pharmaceutical formulations of calixarene molecules
10/19/2011EP2375960A1 Apparatus and methods for containing and delivering therapeutic agents
10/19/2011EP2375912A1 Compositions and methods for the treatment of throat discomfort
1 ... 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 ... 7860